British Fertility Society

Member Login

03-06 June 2019

Gloucester Millennium Hotel, London


Overview & Introduction

Yacoub Khalaf, Chair

This study day aims to give information on providing PGD as part of a  multidisciplinary service delivered by genetic and ART specialists. It will allow attendees to appreciate the burden of genetic disorders and their mode of inheritance whilst acquiring the latest knowledge on reproductive options for couples who are at risk of having a child affected by a genetic disorder. It will also discuss the application of PGS as an option to patients seeking treatment and its advantages and disadvantages. The session aims to ensure an understanding of the typical clinical pathway of PGD and PGS, how both are regulated in the UK, appreciate the embryology lab processes required , to familiarise attendees with the latest genetic diagnostic technologies and clinical scenarios will also be presented. This study day will be of interest to ATSM candidates, Consultants, ART specialists, Nurses, Embryologists and Counsellors.

07 June 2018

Time Session Speaker
08:50 – 08:55 Welcome Yacoub Khalaf
08:55 – 09:15 Introduction to genetic diseases, their mode of inheritance and their burden on health and reproduction Anne Lampe
09:15 – 09:35 Reproductive options available to couples at risk Janine Elson
09:35 – 09:55 The current status of NIPT and prenatal diagnosis Kathy Mann
09:55 – 10:15 An introduction to PGD and PGS and expanded carrier screening Joyce Harper
10:15 – 10:35 PGD counselling and clinical pathway Alison Lashwood
11:00 – 11:30 How does the HFEA regulate PGD and PGS? Erin Barton
11:30 – 12:00 Embryology of PGD and PGS Alpesh Doshi
12:00 – 12:30 PGD and PGS diagnostic technologies Alan Thornhill
13:30 – 14:00 Clinical assessment/ preparation of PGD and PGS couples and factors that affect success and clinical results Tarek El-Toukhy
14:00 – 14:20 MDT interactive session service delivery models Jonathan Skull
14:20 – 15:00 Cases discussions Yacoub Khalaf
15:30 – 16:10 Debate: This house believes that clinical evidence supports routine use of PGS. Against the motion - Yacoub Khalaf, For the motion - Alan Thornhill
16:10 – 16:30 Open discussion Yacoub Khalaf
16:30 – 17:00 Overall discussion of the day Yacoub Khalaf